DNTH vs TFX · rev $6.2M vs P/E 2083, rev $3.05B
Dianthus Therapeutics Inc. (DNTH) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
DNTH currently screens at market cap $4.40B. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the DNTH and TFX stock pages for the full models.
Not investment advice.